Anthera Pharmaceuticals, Inc.
(Other OTC/NBB : ANTH)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -2.71%428.720.0%$5867.90m
BNTXBioNTech SE -4.57%355.630.0%$1225.29m
NVAXNovavax, Inc. -1.52%233.6779.4%$925.09m
SNSSSunesis Pharmaceuticals, Inc. 0.12%8.530.7%$596.28m
AMGNAmgen, Inc. 0.14%217.671.4%$528.68m
REGNRegeneron Pharmaceuticals, Inc. -1.10%645.992.7%$517.02m
GILDGilead Sciences, Inc. -0.62%70.891.0%$419.03m
ILMNIllumina, Inc. -0.55%447.473.5%$378.04m
TECHBio-Techne Corp. 0.93%534.374.5%$331.36m
BIIBBiogen, Inc. -0.29%298.811.7%$291.93m
VRTXVertex Pharmaceuticals, Inc. -0.04%187.021.9%$230.46m
ISEEIVERIC bio, Inc. -1.96%16.040.0%$185.42m
BGNEBeiGene Ltd. 4.27%401.701.3%$166.21m
LIFEaTyr Pharma, Inc. -6.43%9.603.2%$130.36m
KDMNKadmon Holdings, Inc. -0.62%8.770.9%$127.36m

Company Profile

Anthera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines to treat serious and life threatening diseases. It offers Sollpura and blisibimod to treat diseases such as exocrine pancreatic insufficiency and Immunoglobulin A nephropathy. The company was founded by Paul F. Truex on September 9, 2004 and is headquartered in Hayward, CA.